P. Gobbi
-
- Lymphoma Diagnosis and Treatment 15
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 5
- Hematology top 10%
-
- Viral-associated cancers and disorders 4
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 4
-
- Lung Cancer Treatments and Mutations 6
- Gastric Cancer Management and Outcomes 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
P. Gobbi
20 papers receiving 454 citations
Peers
Comparison fields: 5 of 47
- Pathology and Forensic Medicine 329
- Genetics 96
- Hematology 87
- Oncology 195
- Neurology 104
Countries citing papers authored by P. Gobbi
This map shows the geographic impact of P. Gobbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gobbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gobbi more than expected).
Fields of papers citing papers by P. Gobbi
This network shows the impact of papers produced by P. Gobbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gobbi. The network helps show where P. Gobbi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Gobbi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 3 | |
| 2 | 2009 | 48 | |
| 3 | 2008 | 29 | |
| 4 | 2008 | 20 | |
| 5 | 2008 | 53 | |
| 6 | 2008 | 7 | |
| 7 | 2007 | 33 | |
| 8 | 2007 | 19 | |
| 9 | 2006 | 3 | |
| 10 | 2005 | 20 | |
| 11 | 1996 | 25 | |
| 12 | 1996 | 55 | |
| 13 | Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access. | 1995 | 8 |
| 14 | Primary splenic lymphoma: does it exist? | 1994 | 35 |
| 15 | 1993 | 63 | |
| 16 | 1993 | 25 | |
| 17 | MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease. | 1993 | 7 |
| 18 | 1992 | 6 | |
| 19 | 1990 | 8 | |
| 20 | Case report of primary bone lymphoma with disseminated presentation. | 1985 | 2 |
About P. Gobbi
P. Gobbi is a scholar working on Pathology and Forensic Medicine, Genetics, Transplantation, Oncology and Neurology, having authored 20 papers that have together received 469 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral-associated cancers and disorders (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Acute Lymphoblastic Leukemia research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (329 citations), Genetics (96 citations), Hematology (87 citations), Oncology (195 citations) and Neurology (104 citations). P. Gobbi has collaborated with scholars based in Italy and United States. Frequent co-authors include S Tura, Pier Luigi Zinzani, Carla Pieresca, Ercole Brusamolino, E Ascari, Giovanni Grignani, Mauro Fiacchini, Massimo Federico, Silvia Brugnatelli and Monia Marchetti. Their work appears in journals such as Haematologica, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.